CHDR specialises in early-phase clinical drug research. Our mission is to improve the drug development process by collecting as much information as possible regarding the candidate drug in the early phases of development. With this information, we help sponsors make informed decisions regarding the course of clinical development for their product.
Central Nervous System
CHDR is particularly experienced in testing therapies for treating pain and neurodegeneration, as well as psychiatric and sleep disorders. Using comprehensive test batteries – such as PainCart® and NeuroCart® – and imaging techniques, we can provide rich information on the pharmacological effects of candidate drugs early in clinical development.
Immunology & Inflammation
We have a significant track record in the development of therapeutics for a range of immunological diseases. To facilitate a more rational development of anti-inflammatory compounds, CHDR offers reliable and accurate methods to induce inflammatory responses in vitro, ex vivo and in vivo, allowing early evaluation of the immune-modulating effects of new drugs.
Cardiovascular & Metabolic disease
Since our founding over 30 years ago, CHDR has been a leader in the fields of vascular medicine and metabolic disease. Our experience covers the entire spectrum of cardiac and vascular function, including coagulation and organ blood flow measurements, and a range of metabolic assays and challenges.
In immunology, dermatology, vascular medicine, endocrinology, and image-guided surgery, we are developing an array of biomarkers to gain as much information as possible from early clinical drug research. Complementing this wealth of tools, CHDR offers sponsors comprehensive in-house Cardiology Services.
Browse our 1019 publications
The CHDR library contains a wealth of research and innovative publications that pushes our quality of work towards the highest standards.